$ADMA news
The latest ADMA stock news: headlines, filings, AI summaries and sentiment for $ADMA, updated around the clock.
- ADMA Biologics Reports Strong Q3 2026 Growth Driven by ASCENIV and Margin Expansion
- ADMA Biologics Shares Surge Following Third Quarter Earnings Beat
- ADMA BIOLOGICS, INC. - 10-Q Filing
- ADMA BIOLOGICS, INC. - 8-K Filing
- Law Firm Investigates ADMA Biologics for Potential Fiduciary Duty Breach
- Investigation into ADMA Biologics' Board for Potential Fiduciary Duty Breach
- Class Action Lawsuit Filed Against ADMA Biologics Over Alleged Securities Fraud
- Class Action Lawsuit Filed Against ADMA Biologics Amid Allegations of Securities Fraud
- Class Action Lawsuit Filed Against ADMA Biologics Over Alleged Securities Fraud
- Class Action Lawsuit Filed Against ADMA Biologics Amid Allegations of Securities Fraud
- ADMA Biologics Faces Federal Securities Lawsuit Over Alleged Revenue Inflation
- ADMA BIOLOGICS, INC. - 8-K Filing
- ADMA Biologics Receives FDA Approval to Expand ASCENIV Label for Pediatric Patients
- Fund Adds $12 Million to ADMA Biologics Despite Stock Down 58% Year-to-Date
- B Group Adds $12 Million to ADMA Biologics Despite a 58% Share Price Drop Over One Year
- ADMA Biologics Reports Q1 2026 Earnings with Mixed Performance Across Product Lines
- Mizuho Lowers Price Target for ADMA Biologics Inc. to $24
- Cantor Fitzgerald Downgrades ADMA Biologics to Neutral from Overweight